Drugs / edonerpic
edonerpic
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02079909 | Mar 2014 → May 2017 | Alzheimer disease | FUJIFILM Toyama Chemical Co., Ltd. | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | edonerpic | “Edonerpic maleate (T-817MA) protects against Aβ40-induced neurotoxic effects and memory deficits, promotes neurite outgrowth, and preserves hippocampal synapses and spatial...” PMID 31282954 ↗ Nov 2019 |
| Known as | Edonerpic maleate | “Edonerpic maleate (T-817MA) protects against Aβ40-induced neurotoxic effects and memory deficits, promotes neurite outgrowth, and preserves hippocampal synapses and spatial...” PMID 31282954 ↗ Nov 2019 |
| Known as | T-817MA | “Edonerpic maleate (T-817MA) protects against Aβ40-induced neurotoxic effects and memory deficits, promotes neurite outgrowth, and preserves hippocampal synapses and spatial...” PMID 31282954 ↗ Nov 2019 |